Rendering

Component: (Network and Table)
Network
2414407 - Disclosure - Equity-Based Compensation - Schedule of RSUs Granted (Details)
(http://www.amagpharma.com/role/EquityBasedCompensationScheduleOfRsusGrantedDetails)
TableSchedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000792977 (http://www.sec.gov/CIK)
Award Type [Axis]RSUs
Equity compensation plansPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Restricted Stock Units
 
 
 
Outstanding at beginning of year (shares)
654,355  
  
Granted (shares)
725,618  
  
Vested (shares)
(300,567) 
  
Forfeited (shares)
(142,452) 
  
Outstanding at end of year (shares)
936,954  
 
654,355  
 
 
 
Outstanding at end of year and expected to vest (shares)
781,165  
  
Weighted Average Grant Date Fair Value
 
 
 
Beginning balance (USD per share)
36.90  
  
Granted (USD per share)
22.28  
52.71  
22.88  
Vested (USD per share)
30.38  
  
Forfeitures (USD per share)
26.66  
  
Ending balance (USD per share)
28.78  
36.90  
 
Outstanding at end of year and expected to vest (USD per share)
28.79